137 related articles for article (PubMed ID: 21571045)
21. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
22. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
23. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
24. The novel cyclooxygenase-2 inhibitor GW637185X protects against l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.
Aguirre JA; Leo G; Cueto R; Andbjer B; Naylor A; Medhurst AD; Agnati LF; Fuxe K
Neuroreport; 2008 Apr; 19(6):657-60. PubMed ID: 18382281
[TBL] [Abstract][Full Text] [Related]
25. Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity.
Ma Z; Wei X; Fontanilla C; Noelker C; Dodel R; Hampel H; Du Y
Life Sci; 2006 Aug; 79(13):1307-11. PubMed ID: 16707141
[TBL] [Abstract][Full Text] [Related]
26. Quantification of MPTP-induced dopaminergic neurodegeneration in the mouse substantia nigra by laser capture microdissection.
Stephenson D; Ramirez A; Long J; Barrezueta N; Hajos-Korcsok E; Matherne C; Gallagher D; Ryan A; Ochoa R; Menniti F; Yan J
J Neurosci Methods; 2007 Jan; 159(2):291-9. PubMed ID: 16949674
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Turan D; Abdik H; Sahin F; Avşar Abdik E
Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
[TBL] [Abstract][Full Text] [Related]
28. Effects of cysteamine on MPTP-induced dopaminergic neurodegeneration in mice.
Sun L; Xu S; Zhou M; Wang C; Wu Y; Chan P
Brain Res; 2010 Jun; 1335():74-82. PubMed ID: 20380823
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
Kurkowska-Jastrzebska I; Litwin T; Joniec I; Ciesielska A; Przybyłkowski A; Członkowski A; Członkowska A
Int Immunopharmacol; 2004 Oct; 4(10-11):1307-18. PubMed ID: 15313429
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.
McKinley ET; Baranowski TC; Blavo DO; Cato C; Doan TN; Rubinstein AL
Brain Res Mol Brain Res; 2005 Nov; 141(2):128-37. PubMed ID: 16209898
[TBL] [Abstract][Full Text] [Related]
31. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
[TBL] [Abstract][Full Text] [Related]
32. Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats.
Ozen S; Akyol O; Iraz M; Söğüt S; Ozuğurlu F; Ozyurt H; Odaci E; Yildirim Z
J Appl Toxicol; 2004; 24(1):27-35. PubMed ID: 14745844
[TBL] [Abstract][Full Text] [Related]
33. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
34. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice.
Kang JM; Jung JC; Kim H; Lim H; Jang S; Oh S
Arch Pharm Res; 2008 Sep; 31(9):1098-107. PubMed ID: 18806951
[TBL] [Abstract][Full Text] [Related]
35. Antitumor progression potential of caffeic acid phenethyl ester involving p75(NTR) in C6 glioma cells.
Lin WL; Liang WH; Lee YJ; Chuang SK; Tseng TH
Chem Biol Interact; 2010 Dec; 188(3):607-15. PubMed ID: 20836997
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation.
Li R; Peng N; Du F; Li XP; Le WD
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):376-80. PubMed ID: 16624731
[TBL] [Abstract][Full Text] [Related]
37. Caffeic acid phenethyl ester prevents apoptotic cell death in the developing rat brain after pentylenetetrazole-induced status epilepticus.
Yiş U; Topçu Y; Özbal S; Tuğyan K; Bayram E; Karakaya P; Yilmaz O; Kurul SH
Epilepsy Behav; 2013 Nov; 29(2):275-80. PubMed ID: 24012504
[TBL] [Abstract][Full Text] [Related]
38. Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL/6 mice.
Ohashi S; Mori A; Kurihara N; Mitsumoto Y; Nakai M
Neurosci Lett; 2006 Jun; 401(1-2):183-7. PubMed ID: 16581184
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effects of echinacoside in the mouse MPTP model of Parkinson's disease.
Geng X; Tian X; Tu P; Pu X
Eur J Pharmacol; 2007 Jun; 564(1-3):66-74. PubMed ID: 17359968
[TBL] [Abstract][Full Text] [Related]
40. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
